Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Protalix BioTherapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +2 vs. Q1 2026
- Shares held
- 14.5M
- −2.40M (−14.3%) vs. Q1 2026
- Total value
- $33.7M
- −$2.88M (−7.9%) vs. Q1 2026
- New holders
- 18
- 38 more added
- Sold out
- 16
- 17 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $30.9M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $11.9M |
| Q4 2023 | 66 | $17.6M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.45M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.24M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Mak Capital One LLC | 0 | $0 | 0.00% | −3,544,139−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −418,570−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −340,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −207,275−100.0% | Sold out |
| Round Rock Advisors, LLC | 0 | $0 | 0.00% | −192,080−100.0% | Sold out |
| Evergreen Capital Management LLC | 0 | $0 | 0.00% | −171,338−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −124,195−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −67,893−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −19,528−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,589−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,291−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −10,046−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −236−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −128−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |